Phenotypic switching prevention and proliferation/migration inhibition of vascular smooth muscle cells by the ruthenium nitrosyl complex trans-[Ru(NO)Cl(cyclam](PF6 )2.

Mariana Gonçalves de OliveiraFabio G DoroElia TfouniMarta H Krieger

Published in: The Journal of pharmacy and pharmacology (2017)

With great potential to maintain VSMC functionality and prevent IH-associated events, cyclamNO might be a promissory drug for several applications in cardiovascular medicine, as in stents.

Keyphrases

vascular smooth muscle cells
angiotensin ii
signaling pathway
human health
emergency department
adverse drug
drug induced